Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
公司代碼AORT
公司名稱Artivion Inc
上市日期Feb 12, 1993
CEOMackin (James Patrick)
員工數量1600
證券類型Ordinary Share
年結日Feb 12
公司地址1655 Roberts Boulevard N W
城市KENNESAW
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編30144
電話17704193355
網址https://artivion.com/
公司代碼AORT
上市日期Feb 12, 1993
CEOMackin (James Patrick)